P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Alzheimer's & Dementia

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2006.05.437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Can accelerated ageing models inform us on age‐related tauopathies?

  2023cites this paper
• APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice

  2023influential citation
• Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release

  2023cites this paper
• GABA-Positive Astrogliosis in Sleep-Promoting Areas Associated with Sleep Disturbance in 5XFAD Mice

  2023cites this paper
• Animal models of Alzheimer’s disease: preclinical insights and challenges

  2023cites this paper
• Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau

  2023cites this paper
• Dysregulation of neuroproteasomes by ApoE isoforms drives endogenous Tau aggregation

  2023cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Selective neuronal vulnerability to deficits in RNA processing.

  2023cites this paper
• Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy

  2023cites this paper
• HUWE1 Amplifies Ubiquitin Modifications to Broadly Stimulate Clearance of Proteins and Aggregates

  2023cites this paper
• Abeta-induced Presynaptic Release of UBC9 through Extracellular Vesicles involves SNAP23.

  2022cites this paper
• Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau

  2022cites this paper
• Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?

  2022cites this paper
• The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases

  2022cites this paper
• Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer’s disease

  2022cites this paper
• Pathological Human Tau Induces Alterations in the Brain Insulin Signaling Cascade

  2022cites this paper
• Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey

  2022cites this paper
• Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice

  2022cites this paper
• GnRH replacement rescues cognition in Down syndrome

  2022cites this paper
• Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease

  2022cites this paper
• Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease

  2022cites this paper
• All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer’s disease

  2022influential citation
• Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease?

  2022cites this paper
• Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis

  2022influential citation
• Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice

  2022cites this paper
• Sanweidoukou Decoction, a Chinese herbal formula, ameliorates β-amyloid protein-induced neuronal insult via modulating MAPK/NF-κB signaling pathways: studies in vivo and in vitro.

  2021cites this paper
• Synaptic tau: A pathological or physiological phenomenon?

  2021cites this paper
• Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?

  2021cites this paper
• Glial cells and adaptive immunity in frontotemporal dementia with tau pathology.

  2021cites this paper
• Tau Oligomers Neurotoxicity

  2021cites this paper
• The path to progress preclinical studies of age-related neurodegenerative diseases: A perspective on rodent and hiPSC-derived models.

  2021cites this paper
• Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation state.

  2021cites this paper
• Consequences of human Tau aggregation in the hippocampal formation of ageing mice in vivo

  2021cites this paper
• Mesenchymal stem cells after the proprocessing of tanshinone IIA attenuate cognitive deficits and oxidative stress injury in an amyloid β-peptide (25–35)-induced rodent model of Alzheimer’s disease

  2021cites this paper
• A β-secretase modulator decreases Tau pathology and preserves short-term memory in a mouse model of neurofibrillary degeneration

  2021cites this paper
• Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging

  2021cites this paper
• Cholinergic neurodegeneration in Alzheimer disease mouse models.

  2021cites this paper
• Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies

  2021cites this paper
• Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy

  2021influential citation
• THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.

  2021cites this paper
• A ß-Secretase Modulator Decreases Tau Pathology and Preserves Short-Term Memory in a Mouse Model of Neurofibrillary Degeneration

  2021cites this paper
• P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy.

  2021cites this paper
• Spinal Cord Injury Causes Prominent Tau Pathology Associated with Brain Post-Injury Sequela

  2021cites this paper
• Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer’s disease

  2021cites this paper
• Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22

  2021influential citation
• Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons

  2021cites this paper
• Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease

  2020cites this paper
• Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration

  2020cites this paper
• A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

  2020influential citation
• Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice.

  2020cites this paper
• Neuroprotective Brain-Derived Neurotrophic Factor signaling in the TAU-P301L tauopathy zebrafish model.

  2020cites this paper
• Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease

  2020cites this paper
• Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells

  2020cites this paper
• Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer’s Disease

  2020cites this paper
• “Olfactory Three-Needle” Enhances Spatial Learning and Memory Ability in SAMP8 Mice

  2020cites this paper
• Targeting Aggrephagy for the Treatment of Alzheimer’s Disease

  2020cites this paper
• Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology: Running title: BPSD in Alzheimer's disease models.

  2020cites this paper
• Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology

  2020cites this paper
• A novel equilibrative nucleoside transporter 1 inhibitor alleviates Tau-mediated neurodegeneration

  2020cites this paper
• Picalm reduction exacerbates tau pathology in a murine tauopathy model

  2020cites this paper
• Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity

  2020cites this paper
• Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells

  2020cites this paper
• Spatial reference learning deficits in absence of dysfunctional working memory in the TgF344‐AD rat model of Alzheimer's disease

  2020cites this paper
• The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.

  2020cites this paper
• Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy.

  2020cites this paper
• Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice

  2020cites this paper
• Fyn depletion ameliorates tauP301L-induced neuropathology

  2020cites this paper
• Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy

  2020influential citation
• Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration.

  2020cites this paper
• Functional Alterations in the Olfactory Neuronal Circuit Occur before Hippocampal Plasticity Deficits in the P301S Mouse Model of Tauopathy: Implications for Early Diagnosis and Translational Research in Alzheimer’s Disease

  2020cites this paper
• Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models

  2019cites this paper
• A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice

  2019cites this paper
• The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

  2019cites this paper
• Applications and considerations for the use of genetically engineered mouse models in drug development

  2019cites this paper
• Astroglia in Alzheimer's Disease.

  2019cites this paper
• Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor

  2019influential citation
• Encephalopathy induced by Alzheimer brain inoculation in a non-human primate

  2019cites this paper
• The use of 1,5-diaminonaphthalene for matrix-assisted laser desorption/ionization mass spectrometry imaging of brain in neurodegenerative disorders.

  2019cites this paper
• Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.

  2019cites this paper
• Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice

  2019cites this paper
• NLRP3 inflammasome activation drives tau pathology

  2019cites this paper
• Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model.

  2019cites this paper
• Relationship Between Tau, β Amyloid and α-Synuclein Pathologies.

  2019cites this paper
• Animal Models of Alzheimer's Disease

  2019cites this paper
• Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

  2019cites this paper
• Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody

  2019cites this paper
• Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases

  2018influential citation
• Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration

  2018cites this paper
• Correction for “ SLC 39 A 14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice

  2018cites this paper
• Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions.

  2018cites this paper
• SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice

  2018cites this paper
• Hippocampal synaptic plasticity in neurodegenerative diseases: Aß, tau and beyond

  2018cites this paper
• Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability

  2018cites this paper
• Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology

  2018cites this paper
• Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology

  2018cites this paper
• Genome-wide identification of genic and intergenic neuronal DNA regions bound by Tau protein under physiological and stress conditions

  2018cites this paper
• Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator

  2018influential citation
• Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy

  2018cites this paper
• Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease

  2018cites this paper